By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website –
Check out our openings –

Key Statistics

Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN



Sanofi US 


Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 

Company News
Express Scripts to Cover Amgen (AMGN), Regeneron (REGN)'s Pricey New Cholesterol Drugs 10/7/2015 5:51:34 AM
Regeneron (REGN) Forges $325 Million Pain Pact with Mitsubishi Tanabe 10/2/2015 6:10:16 AM
Regeneron (REGN) And Icahn School Of Medicine At Mount Sinai Announce New Antibody Research Agreement 9/24/2015 11:45:56 AM
Regeneron (REGN) Announces Agreement With Biomedical Advanced Research and Development Authority (BARDA) For The Development Of New Antibody Treatment For Ebola 9/22/2015 10:35:57 AM
Regeneron (REGN) Scientists Discover Key to Why Some People's Muscles Suddenly Turn into Bone 9/3/2015 6:15:36 AM
Regeneron (REGN) And Sanofi (SNY) Announce New Positive Praluent (alirocumab) Phase 3 Data Presented At ESC Congress 2015 9/1/2015 7:30:39 AM
Regeneron (REGN) Announces Upcoming 2015 Investor Conference Presentations 8/31/2015 10:25:18 AM
Alnylam (ALNY), The Medicines Company (MDCO)'s Long-Acting Cholesterol Drug May Threaten Amgen (AMGN), Regeneron (REGN)-Sanofi (SNY)'s Blockbusters 8/31/2015 5:55:51 AM
After Sanofi (SNY) Deal Paydays, Regeneron (REGN) Expands Facilities in New York 8/25/2015 7:27:18 AM
Fight Intensifying Over Which Patients Will Get Regeneron (REGN), Sanofi (SNY)'s $15,000 a Year Cholesterol Drug 8/11/2015 6:14:34 AM